Faes Farma, S.A. (BME:FAE)
4.720
+0.035 (0.75%)
Oct 27, 2026, 11:45 AM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.47 billion as of October 26, 2026. It is the 7,522nd most valuable company in the world and the 57th biggest in Spain. Its market cap has increased by 4.95% in one year.
Market Cap
1.47B
Enterprise Value
1.78B
Revenue
711.06M
Global Rank
Country Rank
#57 Spain
PE Ratio
17.60
ChartMarket Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.47B, an increase of 798.61%. That is a compound annual growth rate of 6.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.47B | -8.47% |
| Dec 31, 2025 | 1.61B | 48.28% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.38B |
| Laboratorios Farmaceuticos Rovi | 3.14B |
| Almirall | 2.26B |
| Pharma Mar | 1.18B |
| Clínica Baviera | 849.76M |
| Laboratorio Reig Jofre | 214.22M |
| Prim, S.A. | 211.75M |
| Oryzon Genomics | 204.91M |